Oulu, Finland, May 3, 2022 – Bittium exhibits its innovative products and solutions for cardiology at the ESOC 2022 congress in Lyon, France on 4-6 May 2022. ESOC is the leading forum in Europe for advances in research and clinical care of patients with cerebrovascular disease.
Bittium’s team of Medical Technologies experts will showcase our latest solutions for cardiac monitoring that enable long-term ECG measurements and recordings, early detection of cardiac arrhythmias, and cardiac event monitoring. The new Bittium Faros™ 180L ECG measuring device, which measures at least 14 consecutive days on a single battery charge, will be on display at the exhibition, streamlining prolonged ECG monitoring in stroke patients, improving diagnostic yield, and patient compliance. Bittium´s solutions enable the earlier discharge of patients and the ability to detect and react to arrhythmias faster.
All Bittium’s medical products can be integrated with the cloud-based back-end systems enabling seamless workflow and analysis of data regardless of location. These innovations not only equip clinicians with smarter diagnostics tools but also offer healthcare providers more efficient, time- and resource-saving solutions that are well suited for remote, preventative, and home-based care. The importance of remote care and remote monitoring has increased during the Covid-19 pandemic due to insufficient medical resources and cost pressures. Bittium’s remote monitoring and remote diagnostics solutions can provide solutions for these challenges and allow access to treatment for more patients.
The Medical Technologies team is located at stand B3 exhibiting the following products and solutions:
To register for the event, please visit https://2022.eso-conference.org/ .
Senior Vice President, Medical Technologies
Tel. +358 40 344 3507
Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its over 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology and neurophysiology. Net sales in 2021 were EUR 86.9 million, and operating profit was EUR 3.2 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com